Anticonvulsant-induced toxic epidermal necrolysis: Monitoring the immunologic response

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 1 I, 2000, Pages 157-165

  Leyva, Laura ^a   Torres, Maria José ^a   Posadas, Sinforiano ^a   Blanca, Miguel ^a   Besso, Guillermo ^a   O'Valle, Francisco ^c   Del Moral, Raimundo Garcia ^c   Santamaria, Luis F ^b   Juárez, Carlos ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^b Centre de Investigación ^*  (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

Anticonvulsant; Cutaneous lymphocyte associated antigen; Cytokines; Homing; Severe skin reactions; T lymphocytes; Toxic epidermal necrolysis

Indexed keywords

CARBAMAZEPINE; DEXAMETHASONE; PHENYTOIN; PREDNISONE;

ADULT; AGED; ARTICLE; BLISTER; CASE REPORT; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; FOCAL EPILEPSY; GLIOBLASTOMA; HUMAN; IMMUNOCOMPETENCE; IMMUNOHISTOCHEMISTRY; MALE; MENINGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEIZURE; T LYMPHOCYTE ACTIVATION; TOXIC EPIDERMAL NECROLYSIS;

EID: 0033968503     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(00)90191-X     Document Type: Article

References (32)

1. Lyell A. Toxic epidermal necrolysis (the scalded skin syndrome): a reappraisal. Br J Dermatol 1979;100:69-86.
2. Roujeau JC, Stern RS. Severe cutaneous adverse reactions to drugs. N Engl J Med 1994;331:1272-85.
3. Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, et al. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis. Br J Dermatol 1996;135:6-11.
4. Revuz J, Penso D, Roujeau JC, Guillaume JC, Payne CR, Weschler J. Toxic epidermal necrolysis: clinical findings and prognosis factors in 87 patients. Arch Dermatol 1987;123:1160-5.
5. Guillaume JC, Roujeau JC, Revuz J, Penso D, Touraine R. The culprit drugs in 87 cases of toxic epidermal necrolysis (Lyell syndrome). Arch Dermatol 1987;123:1166-70.
6. Roujeau JC, Guillaume JC, Fabre JP, Penso D, Fléchet ML, Girre JP. Toxic epidermal necrolysis (Lyell syndrome): incidence and drug etiology in France, 1981-1985. Arch Dermatol 1990;126:37-42.
7. Shear NH, Spielberg SP. Anticonvulsant hypersensitivity syndrome: in vitro assessment of risk. J Clin Invest 1988;82:1826-32.
8. Villada G, Roujeau JC, Clérici T, Bourgalt I, Revuz J. Immunopathology of toxic epidermal necrolysis, keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases. Arch Dermatol 1992;128:50-3.
9. Correia O, Delgado L, Ramos JP, Resende C, Fleming Torrinha JA. Cutaneous T-cell recruitment in toxic epidermal necrolysis: further evidence of CD8+ lymphocyte involvement. Arch Dermatol 1993;129:466-8.
10. Miyauchi H, Hosokawa H, Akaeda T, Iba H, Asada Y. T cell subsets in drug-induced toxic epidermal necrolysis: possible pathogenic mechanism induced by CD8-positive cells. Arch Dermatol 1991;127:851-5.
11. Roujeau JC, Dubertret L, Moritz S, Jouault H, Heslan M, Revuz J, et al. Involvement of macrophages and pathology of toxic epidermal necrolysis. Br J Dermatol 1985;113:425-30.
12. Picker LJ, Treer JR, Ferguson-Darnell B, Collins PA, Bergstresser PR, Terstappen LWMM. Control of lymphocyte recirculation in man, II: differential regulation of the cutaneous lymphocyte-associated antigen, a tissue selective homing receptor for skin-homing T cell. J Immunol 1993;150:1122-36.
13. Mauri-Hellweg D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin, and carbamazepine. J Immunol 1995;155:462-72.
14. Chomczysnky P, Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
15. Siebert PD, Lamick JW. Competitive PCR. Nature 1992;359:557-8.
16. Santamaría Babi LF, Moser R, Percz-Soler MT, Picker LJ, Blaser K, Hauser C. Migration of skin-homing T cells across cytokine-activated human endothelial cell layers involves interaction of the cutaneous lymphocyte-associated antigen (CLA), the very late antigen-4 (VLA-4), and the lymphocyte function-associated antigen-1 (LFA-1). J Immunol 1995;154:1543-50.
17. Picker LJ, Michie SA, Rott LS, Butcher EC. A unique phenotype of skin-associated lymphocytes in humans: preferential expression of the HECA-452 epitope by benign and malignant T cells at cutaneous sites. Am J Pathol 1990;136:1053-68
18. Picker LJ, Treer JR, Kishimoto TK, Smith CV, Warnock RA, Butcher EC. ELAM-1 is an adhesion molecule for the skin homing T cells. Nature 1991;349:796-9.
19. Santamaría Babi LF, Picker LJ, Perez-Soler MT, Drzimalla K, Flohr P, Blaser K, et al. Circulating allergen-reactive T cells from patients with atopic dermatitis and allergic contact dermatitis express the skin-selective homing receptor, the cutaneous lymphocyte associated antigen. J Exp Med 1995;181:1935-40.
20. Gonzalez FJ, Carvajal MJ, del Pozo V, Lahoz C, Santamaría L, Blanca M, et al. Erythema multiforme to phenobarbital: involvement of eosinophils and T cells expressing the skin homing receptor. J Allergy Clin Immunol 1997;113:345-7.
21. Friedmann PS, Strickland I, Pirmohamed M, Park K. Investigation of mechanisms in toxic epidermal necrolysis induced by carbamazepine. Arch Dermatol 1994;130:598-604.
22. Roujeau JC, Chosidow O, Saiag P, Guillaume JC. Toxic epidermal necrolysis (Lyell syndrome). J Am Acad Dermatol 1990;23:1039-58.
23. Leung DYM. Immunological basis of chronic allergic diseases: clinical messages from the laboratory bench. Pediatr Res 1997;42:559-68.
24. Halfield SM, Rodgers GH, Marder P, Roehm NW. Patterns of lymphokine production by primary antigen-specific/MHC restricted murine helper T cell clones. Immunol Invest 1991;20:55-73.
25. Sayama K, Yonehara S, Watanabe Y, Miki Y. Expression of Fas antigen on keratinocytes in vivo and induction of apoptosis in cultured keratinocytes. J Invest Dermatol 1994;103:330-4.
26. Paquet P, Nikkels A, Arrese JA, Vanderkelen A, Pietard GE. Macrophages and tumor necrosis factor a in toxic epidermal necrolysis. Arch Dermatol 1994;130:605-8.
27. Costas MA, Kovalovsky D, Artz E. Mechanisms of glucocorticoid sensitivity modulation by cytokines. Medicina 1997;51:75-80.
28. Roujeau JC, Kelly JP, Naldi L, Rzany B, Stem RS, Anderson T, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Engl J Med 1995;333:1600-7.
29. Gonzalez FJ, Carvajal MJ, Leyva L, Juárez C, Blanca M, Santamaria LF. Expression of the cutaneous lymphocyte-associated antigen in circulating T cells in drug allergic reactions. Int Arch Allergy Immunol 1997;113:345-7.
30. Corrigan CJ, Brown PH, Barnes NC, Tsai J-J, Frew AJ, Kay AB. Glucocorticoid resistance in chronic asthma. Am Rev Respir Dis 1991;144:1026-32.
31. Alvarez J, Surs W, Leung DYM, Iklé D, Gelfand EW, Szefler SJ. Steroidresistant asthma: immunologic and pharmacologic features. J Allergy Clin Immunol 1992;89:714-21.
32. Brattsand R, Linden M. Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies. Aliment Pharmacol Ther 1996;10(2 Suppl):81-92.